EmbryoGlue as an embryo transfer medium
Research type
Research Study
Full title
A randomised controlled trial assessing the effectiveness of EmbryoGlue® as an embryo transfer medium in IVF treatment cycles
IRAS ID
216132
Contact name
Tim Child
Contact email
Sponsor organisation
Clinical Trials and Research Governance, University of Oxford
Duration of Study in the UK
2 years, 6 months, 30 days
Research summary
In Vitro Fertilisation (IVF) is an increasingly common treatment for infertility. Clinics which offer IVF are continuously trying to improve their success rates, measured by the numbers of IVF cycles which result in the birth of a live baby. One factor which is thought to have contributed to the success of IVF is the improvements in the embryo culture media, that is, the fluid in which the embryo resides in the laboratory before being replaced into a woman’s womb. This trial seeks to identify if IVF cycles in which a particular culture media called EmbryoGlue is used have better results when compared to IVF cycles in which a conventional embryo transfer media is used.
REC name
North West - Preston Research Ethics Committee
REC reference
17/NW/0272
Date of REC Opinion
10 May 2017
REC opinion
Further Information Favourable Opinion